Semaglutide vs Wegovy for weight loss in Chinese adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial compares a semaglutide injection to the already-approved weight loss drug Wegovy in Chinese adults with obesity. It aims to see if the new option works just as well to help people lose weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your body mass index (BMI) is 28 or higher.
- You have not lost or gained more than 5% of your body weight in the last 3 months.
- You do not have type 1 or type 2 diabetes.
- You have not had any weight-loss surgery or used a weight-loss device before.
- You have no history of pancreatitis, certain thyroid cancers, or recent serious heart problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new weekly injection called GZR18 against the existing drug Wegovy for weight loss in adults who are overweight or obese. It aims to see which is more effective and safe for helping people lose weight and improve related health conditions.
This study tests a new injectable medication (semaglutide) compared to the approved drug Wegovy® for weight loss in people with obesity. It may help you lose weight if you have struggled to keep weight off with diet alone.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This study tracks how well Wegovy (a once-weekly injection for weight loss) works for people in Korea who are just starting the medication. It helps doctors understand real-world results outside of a research clinic.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study observes how Wegovy works in everyday medical practice for people who are starting it for the first time. It will help doctors learn more about its real-life benefits and safety.
Hear when a new Obesity Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.